|Aglaia Oncology Funds||Bilthoven, Netherlands, Utrecht|
|Ashoka India Equity Investment Trust||-|
|Eficor Ventures||Finland, Helsinki, Southern Finland|
|Fortune||China, Guangdong Province, Huizhou|
|Foxconn||T'ai-wan, Taitung County, Taiwan|
|Freedom Financial Network||California, San Mateo, United States|
|MSG Networks||New York, New York, United States|
|Rongming Capital Management||Beijing, Beijing, China|
|SCC Venture V-Oasis||China, Hong Kong, Hong Kong Island|
|SherpaShare||California, Menlo Park, United States|
|SmartCap||Estonia, Harjumaa, Tallinn|
|The CU Healthcare Innovation Fund||Aurora, Colorado, United States|
|TSG Equity Partners||Massachusetts, Stow, United States|
|YI Technology||California, Sunnyvale, United States|
|$225M||18 Jul 2022||Baltimore, Maryland, United States|
|$14M||24 Mar 2022||San Francisco, California, United States|
|$16M||16 Jun 2021||Frederick, Maryland, United States|
|$5M||17 Apr 2020||Baltimore, Maryland, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.